US 11013791
NYVAC-based plasmodium malaria vaccine
granted A61KA61K39/015
Quick answer
US patent 11013791 (NYVAC-based plasmodium malaria vaccine) held by The Government of the United States, as represented by the Secretary of the Army expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Government of the United States, as represented by the Secretary of the Army
- Grant date
- Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K39/015